Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
New Mobile Friendly Web Tool With Interactive Dashboard Gives Individuals the Information They Need on Monkeypox in Advance of Attending Gatherings
Summer is a time when many of us are keen to get away, enjoy the […]
FDA Approves Abbott's New Spinal Cord Stimulation Device; Provides Tailored Relief to Multiple Pain Areas and Adds More Treatment Options for Evolving Pain Conditions
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved its […]
Roche Launches a Digital PCR System, a Powerful New Diagnostics Platform in the Fight Against Cancer and Other Diseases
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Digital LightCyclerⓇ System, Roche’s first […]
Gilead Announces First Global Regulatory Approval of Sunlenca® (Lenacapavir), the Only Twice-yearly HIV Treatment Option
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has granted Marketing […]
£10.4m Full-service Contract Signed With Existing Big Pharma Client
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world […]
Roche Launches COVID-19 Test That Detects and Differentiates the Emerging Variant of Interest BA.2.75
Roche (SIX: RO, ROG;OTCQX: RHHBY) and its subsidiary TIB Molbiol have developed a COVID-19 test for […]
NHS Trials Smart Goggles to Give Nurses More Time With Patients
High tech goggles will be worn by community nurses on home visits to free up […]
AIRS Medical Raises $20M in Series B Funding
AIRS Medical, a healthcare startup based in South Korea and a member of the Born2Global Centre, recently announced that […]
Ubie, Japanese Health-tech Startup, Raises $26.2 Million in Series C, $59.8 Million in Total
Ubie, Inc., a healthcare AI startup with the mission “To develop a healthcare guide for everyone,” […]
DotLab Announces Three Granted Patents for Its Non-invasive Test for Endometriosis, DotEndo™
DotLab, a medical diagnostics company, announced that the United States Patent and Trademark Office has […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more